During the past decade, Hospital Ampang conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 11 clinical trials were completed, i.e. on average, 31.4% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 9 clinical trials were completed. i.e. 56.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Ampang" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Apellis Pharmaceuticals, Inc." with 4 trials sponsored, "Baxalta now part of Shire" with 4 trials sponsored, "Protagonist Therapeutics, Inc." with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Ampang" #1 collaborator was "Baxalta Innovations GmbH, now part of Shire" with 2 trials as a collaborator, "Ministry of Health, Malaysia" with 2 trials as a collaborator, "Ampang Hospital, Malaysia" with 1 trials as a collaborator, "Basilea Pharmaceutica" with 1 trials as a collaborator and "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Ampang" are "Hemophilia A" (4 trials), "Paroxysmal Nocturnal Hemoglobinuria" (4 trials), "Crohn's Disease" (2 trials), "Erosive Esophagitis" (2 trials) and "Ineffective Erythropoiesis" (2 trials). Many other conditions were trialed in "Hospital Ampang" in a lesser frequency.

Most popular intervention types in "Hospital Ampang" are "Drug" (29 trials), "Biological" (7 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "PEGylated Recombinant Factor VIII" (3 trials), "PTG-300" (3 trials), "Pegcetacoplan" (3 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Ampang" are 37 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Ampang". undefined are not yet recruiting, 9 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Hospital Ampang, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Ampang, 3 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".